BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29955146)

  • 21. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
    Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients.
    Sainati L; Matutes E; Mulligan S; de Oliveira MP; Rani S; Lampert IA; Catovsky D
    Blood; 1990 Jul; 76(1):157-62. PubMed ID: 2364167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.
    Langabeer SE; O'Brien D; Liptrot S; Flynn CM; Hayden PJ; Conneally E; Browne PV; Vandenberghe E
    Int J Lab Hematol; 2012 Aug; 34(4):417-21. PubMed ID: 22313586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical presentation of hairy cell leukemia: Significance of CD200 on flow cytometry.
    Rahman K; Kumari S; Singh MK; Gupta R; Yadav G; Kumari N; Nityan S
    J Cancer Res Ther; 2018; 14(5):1130-1134. PubMed ID: 30197362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
    Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trisomy 12 in chronic lymphocytic leukemia and hairy cell leukemia: a cytogenetic and interphase cytogenetic study.
    Cuneo A; Bigoni R; Balboni M; Carli MG; Piva N; Fagioli F; Latorraca A; Wlodarska I; van den Berghe H; Castoldi G
    Leuk Lymphoma; 1994 Sep; 15(1-2):167-72. PubMed ID: 7858495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variant hairy-cell leukemia: immunophenotypic and ultrastructural study of a case].
    Palomera L; García Díez I; Martínez García R
    Sangre (Barc); 1991 Apr; 36(2):135-9. PubMed ID: 1866652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hairy cell leukemia variant developing in a background of polycythemia vera.
    Kelly NP; Alkan S; Nand S
    Arch Pathol Lab Med; 2003 Apr; 127(4):e209-11. PubMed ID: 12683904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
    Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
    Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
    [No Abstract]   [Full Text] [Related]  

  • 31. Hairy cell leukemia variant: fact or fiction.
    Cessna MH; Hartung L; Tripp S; Perkins SL; Bahler DW
    Am J Clin Pathol; 2005 Jan; 123(1):132-8. PubMed ID: 15762289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
    Aljurf M; Cornbleet PJ; Michel F
    Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD27-positive hairy cell leukemia-Japanese variant.
    Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
    Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
    Wang Y; Wang T; Yu Y; Wang Q; Yan Y; Li R; Sun Q; Xiong W; Lyu R; Yu Z; Liu W; Sui W; Huang W; Wang H; Li C; Wang J; Zou D; An G; Wang J; Qiu L; Yi S
    Ann Hematol; 2022 Jun; 101(6):1201-1210. PubMed ID: 35437610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on hairy cell leukemia.
    Kreitman RJ; Arons E
    Clin Adv Hematol Oncol; 2018 Mar; 16(3):205-215. PubMed ID: 29742076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-pathological profile of Hairy cell leukemia: critical insights gained at a tertiary care cancer hospital.
    Galani KS; Subramanian PG; Gadage VS; Rahman K; Ashok Kumar MS; Shinde S; Mahadik S; Ansari R; Sengar M; Menon H; Nair R; Gujral S
    Indian J Pathol Microbiol; 2012; 55(1):61-5. PubMed ID: 22499303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multilobular variant of hairy cell leukemia with morphologic similarities to T-cell lymphoma.
    Hanson CA; Ward PC; Schnitzer B
    Am J Surg Pathol; 1989 Aug; 13(8):671-9. PubMed ID: 2665535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
    Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Cornet E
    Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.